Prof Henrik Zetterberg, Sweden
March 24, 2022
At ADPD 2022, Professor Henrik Zetterberg explains why he's pioneering research into blood-based biomarkers for Alzheimer's disease to allow for the effective use of innovative disease-modifying treatments in the future.
You are Leaving Medically
By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.
You are Leaving the Global Medically Site
By following this link, you are being redirected to another Roche page.